Company performance
Current Price
as of Jan 23, 2025$1.76
P/E Ratio
N/A
Market Cap
$267.69M
Description
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.
Metrics
Overview
- HQCary, NC
- SectorHealth Technology
- IndustryBiotechnology
- TickerHRTX
- Price$1.76+7.98%
Trading Information
- Market cap$267.69M
- Float99.29%
- Average Daily Volume (1m)1,498,967
- Average Daily Volume (3m)3,238,642
- EPS-$0.18
Company
- Revenue$137.74M
- Rev growth (1yr)4.38%
- Net income-$4.85M
- Gross margin71.17%
- EBITDA margin-11.82%
- EBITDA-$3.88M
- EV$411.49M
- EV/Revenue2.99
- P/EN/A
- P/S1.95
- P/BN/A
Documents
SEC Filings
Earnings Calls
Factset Street Account